RHOA and cardiac hypertrophy: Our previous studies have reported that inhibition of FPPS attenuates angiotensin II-induced cardiac hypertrophy and fibrosis by deceasing RhoA activity10 while overexpression of FPPS induces cardiac hypertrophy and dysfunction by increasing RhoA expression11.